Neo Ivy Capital Management Makes New Investment in Cognex Corporation $CGNX

Neo Ivy Capital Management purchased a new stake in shares of Cognex Corporation (NASDAQ:CGNX) during the 2nd quarter, HoldingsChannel.com reports. The fund purchased 21,992 shares of the scientific and technical instruments company’s stock, valued at approximately $698,000.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Geneos Wealth Management Inc. grew its holdings in Cognex by 402.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after acquiring an additional 736 shares in the last quarter. Penserra Capital Management LLC purchased a new stake in shares of Cognex in the 2nd quarter worth approximately $29,000. TD Waterhouse Canada Inc. bought a new position in shares of Cognex during the second quarter valued at approximately $29,000. MassMutual Private Wealth & Trust FSB increased its holdings in Cognex by 231.9% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,082 shares of the scientific and technical instruments company’s stock valued at $34,000 after buying an additional 756 shares during the period. Finally, Farther Finance Advisors LLC raised its stake in Cognex by 31.5% in the second quarter. Farther Finance Advisors LLC now owns 1,277 shares of the scientific and technical instruments company’s stock worth $40,000 after buying an additional 306 shares in the last quarter. 88.12% of the stock is currently owned by institutional investors.

Cognex Trading Up 5.8%

NASDAQ CGNX opened at $36.89 on Friday. Cognex Corporation has a 12-month low of $22.67 and a 12-month high of $49.76. The company has a fifty day simple moving average of $43.41 and a two-hundred day simple moving average of $38.25. The stock has a market cap of $6.18 billion, a P/E ratio of 57.64 and a beta of 1.52.

Cognex (NASDAQ:CGNX) last released its earnings results on Wednesday, October 29th. The scientific and technical instruments company reported $0.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.06. The firm had revenue of $264.00 million for the quarter, compared to the consensus estimate of $261.86 million. Cognex had a return on equity of 8.26% and a net margin of 11.33%.The firm’s revenue was up 18.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.20 EPS. Cognex has set its Q4 2025 guidance at 0.190-0.24 EPS. As a group, sell-side analysts forecast that Cognex Corporation will post 0.61 earnings per share for the current year.

Cognex Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 28th. Shareholders of record on Thursday, November 13th will be issued a $0.085 dividend. The ex-dividend date of this dividend is Thursday, November 13th. This is a positive change from Cognex’s previous quarterly dividend of $0.08. This represents a $0.34 annualized dividend and a yield of 0.9%. Cognex’s dividend payout ratio is currently 53.13%.

Insider Activity

In other Cognex news, EVP Sheila Marie Dipalma sold 2,000 shares of Cognex stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $45.03, for a total transaction of $90,060.00. Following the completion of the transaction, the executive vice president owned 6,582 shares in the company, valued at approximately $296,387.46. This trade represents a 23.30% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Robert Willett sold 6,704 shares of the business’s stock in a transaction dated Tuesday, October 21st. The shares were sold at an average price of $49.51, for a total value of $331,915.04. The SEC filing for this sale provides additional information. Insiders have sold a total of 10,706 shares of company stock worth $512,065 over the last ninety days. 1.60% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. UBS Group reaffirmed a “buy” rating and set a $58.00 target price on shares of Cognex in a research report on Friday, October 31st. KeyCorp restated an “overweight” rating and set a $50.00 price objective on shares of Cognex in a research note on Friday, October 31st. The Goldman Sachs Group raised their price objective on Cognex from $36.00 to $40.00 and gave the company a “sell” rating in a research report on Tuesday, September 16th. Barclays reiterated an “overweight” rating and issued a $56.00 target price (up from $55.00) on shares of Cognex in a report on Friday, October 31st. Finally, JPMorgan Chase & Co. started coverage on shares of Cognex in a research report on Monday, September 15th. They set a “neutral” rating and a $45.00 price target for the company. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $46.20.

Cognex Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.